$BFRI
Biofrontera Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$0.940
▲+0.86%+$0.008
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBiofrontera Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is BFRI up today? It is at $0.940 (+0.86%), and our scanner flagged it 52 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BFRI spikes, and full due diligence on BFRI — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BFRI 52 times in the last 30 days. Create a free account to track $BFRI, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BFRI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BFRI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAnnounces FDA Approval of Ameluz® Red Light PDT for the Treatment of Superficial Basal Cell CarcinomaReported (aminolevulinic acid hydrochloride) topical gel, 10%, in combination with photodynamic therapy using the BF-RhodoLED®Reported to the Skin Cancer Foundation. Published estimates suggest that the superficial subtype accounts for approximately 15%-20% of BCC cases,Reported after the start of the last PDT cycle. This rigorous target was achieved in 66% of subjects treated with Ameluz PDT (95/145) compared, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Leffler Eugene Frederick Officer | Other | 31K 0.2% of company | added 18% | 206K | n/a | Jul 28, 26 |
Luebbert Hermann Officer | Other | 63K 0.4% of company | added 22% | 353K | n/a | Jul 28, 26 |
Leffler Eugene Frederick Officer | Other | 88K 0.6% of company | added 100% | 175K | n/a | Mar 5, 26 |
Luebbert Hermann Officer | Other | 138K 0.9% of company | added 90% | 290K | n/a | Mar 5, 26 |
Leffler Eugene Frederick Officer | Other | 88K 0.6% of company | n/a | 88K | n/a | Sep 10, 25 |
Luebbert Hermann Officer | Other | 138K 0.9% of company | added 100% | 153K | n/a | Sep 10, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on BFRI from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BFRI today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
BFRI last traded at $0.940, up 0.86% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Biofrontera Inc. Common Stock (BFRI) is next expected to report earnings on Wednesday, November 11, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The BFRI Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BFRI 52 times in the last 30 days.
BFRI (Biofrontera Inc. Common Stock) trades on XNAS, with a market cap of about $14M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BFRI for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BFRI discussion
Sign in to ask a question or join the discussion.